The DoDo experience: an alternative antiretroviral 2-drug regimen of doravirine and dolutegravir.
- Resource Type
- Article
- Source
- Infection; Dec2023, Vol. 51 Issue 6, p1823-1829, 7p
- Subject
HIV infections HIV-positive persons CARDIOVASCULAR diseases risk factors HIV integrase inhibitors COMBINATION drug therapy SCIENTIFIC observation VIRAL load ANTIRETROVIRAL agents TREATMENT effectiveness NON-nucleoside reverse transcriptase inhibitors CD4 lymphocyte count DESCRIPTIVE statistics RESEARCH funding LONGITUDINAL method THERAPEUTICS - Language
- ISSN
- 03008126